The landscape of dementia diagnosis has evolved dramatically with the arrival of sophisticated biomarkers, like amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years ahead of symptoms emerge. Even though these technological advancements represent exceptional development in being familiar with neurod